TherapeuticsMD, Inc.TXMDNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank79
3Y CAGR+25.6%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+25.6%/yr
vs +15.8%/yr prior
Acceleration
+9.8pp
Accelerating
Percentile
P79
Within normal range
vs 3Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202465.45%
202394.69%
202259.93%
202133.05%
20203.04%
2019-35.02%
2018-57.51%
201718.37%
20166.68%
2015-35.62%